Capital Asset Advisory Services LLC Vertex Pharmaceuticals Inc Transaction History

Capital Asset Advisory Services LLC

  • $2.01 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$234.96 - $292.55 $213,578 - $265,927
-909 Closed
0 $0
Q1 2022

Apr 29, 2022
BUY
$221.42 - $260.97 $201,270 - $237,221
909 New
909 $237,000
Q2 2021

Aug 06, 2021
SELL
$187.49 - $221.1 $224,613 - $264,877
-1,198 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$207.02 - $241.31 $153,608 - $179,052
742 Added 162.72%
1,198 $257,000
Q4 2020

Mar 02, 2021
BUY
$207.01 - $276.09 $94,396 - $125,897
456 New
456 $108,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email